NFKB1 and Autoimmunity: Moreover, our results showing first positive and then negative regulation of NF-κB activation by MALT1 indicate that therapeutic intervention with MALT1 inhibitors for autoimmunity or lymphoid neoplasia needs to be considered carefully.